The application of gene editing technology is currently limited by the lack of safe and efficient methods to deliver RNA-guided endonucleases to target cells. We engineered lentivirus-based nanopartic
Background Our goal for the next years is to install precise edits to human genomes and to evaluate their effect at scale, as well as in different genetic contexts. The toolbox of choice is CRISPR/Cas
